AZ, J&J tweaking COVID shots to reduce clotting risks; report
pharmaphorum
JULY 14, 2021
A few weeks ago, scientists in Germany said they had identified a possible mechanism behind the side effect related to the adenoviral vectors that both the AZ and J&J vaccines use to deliver the genetic code that stimulates the body to make the SARS-CoV-2 spike protein and stimulate an immune response.
Let's personalize your content